Gain Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Gain Therapeutics's estimated annual revenue is currently $6.7M per year.
- Gain Therapeutics's estimated revenue per employee is $215,000
Employee Data
- Gain Therapeutics has 31 Employees.
- Gain Therapeutics grew their employee count by -11% last year.
Gain Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Medical Officer | Reveal Email/Phone |
2 | Chief Medical Officer | Reveal Email/Phone |
3 | SVP Research | Reveal Email/Phone |
4 | VP Finance | Reveal Email/Phone |
5 | SVP Quality and CMC | Reveal Email/Phone |
6 | SVP Finance | Reveal Email/Phone |
7 | Manager Investor Relations & Public Relations | Reveal Email/Phone |
8 | Técnico de laboratorio | Reveal Email/Phone |
9 | Research Software Engineer | Reveal Email/Phone |
Gain Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 15 | -32% | N/A | N/A |
#10 | $10.1M | 48 | -9% | N/A | N/A |
What Is Gain Therapeutics?
Gain Therapeutics is a preclinical stage biotech company developing a class of next generation brain-penetrant non-competitive pharmacological chaperones for the treatment of devastating diseases using the proprietary SEE-Tx® technology. The company has several discovery programs in lysosomal storage diseases and CNS indications at various stages of development, all of which validate the platform and offer significant partnering opportunities. Gain Therapeutics was established in 2017 in Lugano by experienced biotech and pharma entrepreneurs.
keywords:N/A
N/A
Total Funding
31
Number of Employees
$6.7M
Revenue (est)
-11%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Gain Therapeutics News
InvestorsObserver is giving Gain Therapeutics Inc (GANX) an Analyst Rating Rank of 72, meaning GANX is ranked higher by analysts than 72% of...
Gain Therapeutics, Inc. is transforming the drug discovery paradigm with structurally targeted allosteric regulators identified with its...
BETHESDA, Md., April 12, 2022 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (Gain), a biotechnology company transforming the...
Other Companies in Lugano
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | N/A | 33 | 32% | N/A |
#2 | $9.8M | 54 | 8% | N/A |
#3 | $16M | 55 | -8% | N/A |
#4 | N/A | 66 | 10% | N/A |
#5 | $9M | 69 | 21% | N/A |